Cargando…

Novel Epigenetic Target Therapy for Prostate Cancer: A Preclinical Study

Epigenetic events are critical contributors to the pathogenesis of cancer, and targeting epigenetic mechanisms represents a novel strategy in anticancer therapy. Classic demethylating agents, such as 5-Aza-2′-deoxycytidine (Decitabine), hold the potential for reprograming somatic cancer cells demons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naldi, Ilaria, Taranta, Monia, Gherardini, Lisa, Pelosi, Gualtiero, Viglione, Federica, Grimaldi, Settimio, Pani, Luca, Cinti, Caterina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031137/ https://www.ncbi.nlm.nih.gov/pubmed/24851905 http://dx.doi.org/10.1371/journal.pone.0098101

Ejemplares similares

Newly Engineered Magnetic Erythrocytes for Sustained and Targeted Delivery of Anti-Cancer Therapeutic Compounds
por: Cinti, Caterina, et al.
Publicado: (2011)

Erythro–Magneto–HA–Virosome: A Bio-Inspired Drug Delivery System for Active Targeting of Drugs in the Lungs
por: Vizzoca, Alessio, et al.
Publicado: (2022)

Time-course gene profiling and networks in demethylated retinoblastoma cell line
por: Malusa, Federico, et al.
Publicado: (2015)

Ensemble inference by integrative cancer networks
por: Mora, Antonio, et al.
Publicado: (2014)

Searching for the Perfect Wave: The Effect of Radiofrequency Electromagnetic Fields on Cells
por: Gherardini, Lisa, et al.
Publicado: (2014)

Separate and Combined Effects of DNMT and HDAC Inhibitors in Treating Human Multi-Drug Resistant Osteosarcoma HosDXR150 Cell Line
por: Capobianco, Enrico, et al.
Publicado: (2014)

Inflammation blood and tissue factors of plaque growth in an experimental model evidenced by a systems approach
por: Pelosi, Gualtiero, et al.
Publicado: (2014)

Secreted proteins from carotid endarterectomy: an untargeted approach to disclose molecular clues of plaque progression
por: Rocchiccioli, Silvia, et al.
Publicado: (2013)

Site-Specific Secretome Map Evidences VSMC-Related Markers of Coronary Atherosclerosis Grade and Extent in the Hypercholesterolemic Swine
por: Rocchiccioli, Silvia, et al.
Publicado: (2015)

Network assessment of demethylation treatment in melanoma: Differential transcriptome-methylome and antigen profile signatures
por: Jiang, Zhijie, et al.
Publicado: (2018)

Pathway landscapes and epigenetic regulation in breast cancer and melanoma cell lines
por: El Baroudi, Mariama, et al.
Publicado: (2014)

A challenging recurrent thoracic disc herniation
por: Capece, Mara, et al.
Publicado: (2023)

Preclinical Models in Prostate Cancer: Resistance to AR Targeting Therapies in Prostate Cancer
por: Devlies, Wout, et al.
Publicado: (2021)

FAT1: a potential target for monoclonal antibody therapy in colon cancer
por: Pileri, Piero, et al.
Publicado: (2016)

Epigenetic modulators as therapeutic targets in prostate cancer
por: Graça, Inês, et al.
Publicado: (2016)

PSMA-Specific CAR-Engineered T Cells Eradicate Disseminated Prostate Cancer in Preclinical Models
por: Zuccolotto, Gaia, et al.
Publicado: (2014)

Multitype Network-Guided Target Controllability in Phenotypically Characterized Osteosarcoma: Role of Tumor Microenvironment
por: Sharma, Ankush, et al.
Publicado: (2017)

Multimodal imaging guided preclinical trials of vascular targeting in prostate cancer
por: Kalmuk, James, et al.
Publicado: (2015)

Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response
por: Ashrafizadeh, Milad, et al.
Publicado: (2022)

Preclinical and clinical progress for HDAC as a putative target for epigenetic remodeling and functionality of immune cells
por: Zhang, Sijia, et al.
Publicado: (2021)

Current advances of targeting epigenetic modifications in neuroendocrine prostate cancer
por: Cheng, Wen-Chi, et al.
Publicado: (2021)

Epigenetic therapies by targeting aberrant histone methylome in AML: molecular mechanisms, current preclinical and clinical development
por: Tsai, C T, et al.
Publicado: (2017)

Preclinical models and evaluation criteria of prostatitis
por: He, Hailan, et al.
Publicado: (2023)

Epigenetics in Prostate Cancer
por: Albany, Costantine, et al.
Publicado: (2011)

Preclinical and Clinical Epigenetic-Based Reconsideration of Beckwith-Wiedemann Syndrome
por: Papulino, Chiara, et al.
Publicado: (2020)

Cervical spine arachnoid cyst complicated by spontaneous intracystic hemorrhage: Case report and review of the literature
por: Mastantuoni, Ciro, et al.
Publicado: (2022)

Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients
por: Ruggeri, Clarissa, et al.
Publicado: (2017)

Preclinical Efficacy of a PARP-1 Targeted Auger-Emitting Radionuclide in Prostate Cancer
por: Sreekumar, Sreeja, et al.
Publicado: (2023)

Preclinical Evaluation of a PSMA-Targeting Homodimer with an Optimized Linker for Imaging of Prostate Cancer
por: Murce, Erika, et al.
Publicado: (2023)

Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research
por: Melas, Philippe A., et al.
Publicado: (2021)

Targeting SELPLG/P‐selectin glycoprotein ligand 1 in preclinical ARDS: Genetic and epigenetic regulation of the SELPLG promoter
por: Sun, Xiaoguang, et al.
Publicado: (2023)

New Insights into the Androgen-Targeted Therapies and Epigenetic Therapies in Prostate Cancer
por: Godbole, Abhijit M., et al.
Publicado: (2011)

A Novel Flavonoid Composition Targets Androgen Receptor Signaling and Inhibits Prostate Cancer Growth in Preclinical Models()()
por: Mamouni, Kenza, et al.
Publicado: (2018)

Novel platinum bipolar electrode for irreversible electroporation in prostate cancer: preclinical study in the beagle prostate
por: Lim, Bumjin, et al.
Publicado: (2021)

Epigenetic regulation of prostate cancer
por: Chin, Suyin P., et al.
Publicado: (2011)

Epigenetic regulation of prostate cancer
por: Wang, Ruixin, et al.
Publicado: (2019)

Epigenetics in prostate cancer treatment
por: Jones, Katelyn, et al.
Publicado: (2021)

Editorial: Epigenetics in prostate cancer
por: Baniahmad, Aria, et al.
Publicado: (2023)

Preclinical and Clinical Status of PSMA-Targeted Alpha Therapy for Metastatic Castration-Resistant Prostate Cancer
por: Juzeniene, Asta, et al.
Publicado: (2021)

Preclinical Assessment of the Combination of PSMA-Targeting Radionuclide Therapy with PARP Inhibitors for Prostate Cancer Treatment
por: Ruigrok, Eline A. M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mhgd5pfudm83oot3rj5e4a19fl